Jung Choi files SEC Form 4 disclosures for Global Blood Therapeutics, Inc.. They have made 12 open-market trades across 2 companies since 2015, most recently 2025-12-01.
CIK 0001650126
2 open-market purchases totalling $638K since 2015, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GBT | 226,672 | $15.5M |
| ANNX | 33,000 | $113K |
| Total | $15.6M |
Shares reported on the most recent Form 4, priced at the 2025-12-03 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANNX | BUY | 2025-12-01 | 2025-12-03 | $4.19 | $138K | +10.5% | +5.5% | +22.2% |
| GBT | SELL | 2018-05-17 | 2018-05-21 | $48.25 | $145K | +8.9% | -7.7% | +8.2% |
| GBT | SELL | 2018-04-17 | 2018-04-19 | $45.50 | $137K | +5.6% | +6.7% | -1.8% |
| GBT | SELL | 2018-03-16 | 2018-03-20 | $54.15 | $162K | -13.9% | -16.3% | -18.7% |
| GBT | SELL | 2018-02-16 | 2018-02-21 | $62.95 | $189K | -1.9% | -22.8% | -24.7% |
| GBT | SELL | 2018-01-17 | 2018-01-18 | $52.85 | $159K | +11.4% | +23.2% | -14.7% |
| GBT | SELL | 2017-12-18 | 2017-12-20 | $36.55 | $219K | +13.4% | +44.4% | +41.9% |
| GBT | SELL | 2017-11-17 | 2017-11-21 | $39.75 | $119K | +3.8% | +0.7% | +72.1% |
| GBT | SELL | 2017-10-17 | 2017-10-18 | $32.65 | $98K | +20.0% | +25.8% | +61.8% |
| GBT | SELL · 10b5-1 | 2017-09-29 | 2017-10-02 | $30.00 | $90K | +6.5% | +26.2% | +34.4% |
| GBT | SELL | 2017-08-31 | 2017-09-05 | $30.00 | $90K | -2.1% | +12.9% | +39.0% |
| GBT | SELL | 2017-07-21 | 2017-07-25 | $30.00 | $90K | +2.6% | -3.7% | +12.0% |
| GBT | BUY | 2015-08-17 | 2016-03-14 | $20.00 | $500K | -14.8% | +24.3% | +33.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.